Clinical Trial Update: Phenserine on the Alzheimer's Treatment Horizon, Study 1 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for Phenserine in Alzheimer's disease and mild cognitive impairment; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Phenserine (phenserine)

Snippet

Sponsor: Helse Stavanger HF | Conditions: Alzheimer Disease, Mild Cognitive Impairment | Phase 1 | Status: NOT_YET_RECRUITING